StemProtein Awarded U.S. Patent for Biodegradable Microneedle Device

SAN DIEGO, Aug. 23, 2021 /PRNewswire/ — StemProtein, LLC (a subsidiary of Stemedica Cell Technologies, Inc.) a leading manufacturer of physiologically balanced growth factors, exosomes, and tissue-restoring proteins received United States Patent No. 10,973,757 entitled “Biodegradable…

About the Author

has written 41842 stories on this site.

Copyright © 2010 Business and Corporate News.